Bicoll News

Research Taxation Support for German Entities: Forschungszulage

Forschungszulage in Deutschland

Seit dem 01.01.2020 bekommen Unternehmen mit Sitz in Deutschland steuerliche Begünstigungen für ihre Forschungsausgaben. Auch die Auftragsforschung darf zu 15% geltend gemacht werden. Das bedeutet, einen Auftrag bei Bicoll koennen Unternehmen nun zu 15% als Forschungszulage zurückerstattet bekommen. Seit 20 …

Read more

Bicoll Celebrates 20th Anniversary

Bicoll celebrates 20 year anniversary

This year marks the 20th anniversary of Bicoll. On November 29th, 2000 we embarked on this exciting journey to deliver research services and natural compound libraries, and enable our partners to develop new effective drugs for patients. We would like …

Read more

Patient-twin on inflammatory diseases

Bicoll joins in HVC Kyoto 2020. The provided pitch dwell upon current project in the field of inflammatory diseases. PATIENT-TWIN ON INFLAMMATORY DISEASES (PTID)Precision medicine: individualized discovery of compounds through lab-on-a-chip technology using plant libraries and patient samples for the …

Read more

Natural compounds experts at German pavilion, BioJapan 2020

Bicoll exhibits at BioJapan 2020, 14-16 October, Yokohama Bio Japan is Asia’s Premier Partnering Event for the Global Biotechnology Industry. For almost two decades It has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating …

Read more

Symposium „Academia Meets Industry – Industry Meets Academia“

January, 2-3, 2020 – Symposium “Academia meet Industry” – Presentation on current results of the SimLeap project “Biologically relevant small molecules: Taste active components identified by data-mining of Chinese historical manuscripts“. Dr. Kai Lamottke gave a talk on the current …

Read more

Bio International Convention 2020

June, 8-11, 2020 – Bicoll exhibits under the roof of German Pavilion at Bio International Convention 2020 in San Diego. Bicoll owns small molecule, property-based isolation technologies to identify beneficial compounds (Bifrac N™ and Bipreselect™). These technologies turn plant extracts …

Read more